Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 17/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 7/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL4800289 | 0.77 | SRC (0.35) | L3MBTL1 | |
| SCHEMBL13032878 | 0.77 | POLB (0.40) | LMNAL3MBTL1 | |
| SCHEMBL8491878 | 0.76 | ACHE (0.44) | L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL6428898 | 0.76 | KCNH2 (0.48) | — | |
| Trifluoromethanesulfonic Acid SCHEMBL38665301 | 0.75 | MAPT (0.39) | L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL5705540 | 0.75 | MAPT (0.39) | L3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL12096566 | 0.75 | PSMB8 (0.32) | LMNA | |
| SCHEMBL4532046 | 0.74 | KMT2A (0.37) | FFAR1 | |
| SCHEMBL118743 | 0.74 | MAPT (0.41) | L3MBTL1 | |
| SCHEMBL6957183 | 0.73 | NPC1 (0.40) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5879894-A | DETECTION AND/OR QUANTITATION OF AT LEAST TWO SUBSTANCES IN A TEST SAMPLE; APPLICATION IN CLINICAL DIAGNOSTICS | CHIRON DIAGNOSTICS CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |